Anthropic said Claude autonomously designed de novo protein binders that bound 14 of 15 targets after independent wet-lab testing by Adaptyv Bio and Twist Bioscience, with campaign hit rates of about 22% to 35% versus a typical 10% to 15% field baseline.Anthropic framed the work as an early, lab-validated test of whether a general model can run a binder-design campaign that has historically taken specialists weeks or months per target.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.